Keyphrases
Interleukin-1β
100%
Phase I Trial
100%
Toxic Effects
100%
Hematologic Effects
100%
Advanced Malignancies
100%
Indomethacin
27%
Maximum Tolerated Dose
18%
Hypotension
18%
Fever
9%
Antiproliferative Activity
9%
Cortisol
9%
Interleukin-6
9%
Cancer Patients
9%
Cholesterol
9%
Dose-limiting Toxicity
9%
In Cancer
9%
Testosterone
9%
Triglycerides
9%
Headache
9%
Infarction
9%
Platelet Count
9%
Renal Insufficiency
9%
Thyroid Hormones
9%
C-reactive Protein
9%
Cancer Treatment
9%
Systemic Vascular Resistance
9%
Pressors
9%
Myalgia
9%
Nausea-vomiting
9%
Chronic Abdominal Pain
9%
WBC Count
9%
Bone Marrow Cellularity
9%
Myeloid Cells
9%
Megakaryocytes
9%
Segmented Neutrophils
9%
Induced Hypotension
9%
Anti-infective
9%
Immunostimulatory
9%
Myeloprotective
9%
Advanced Solid Malignancies
9%
Pharmacology, Toxicology and Pharmaceutical Science
Phase I Trials
100%
Interleukin 1alpha
100%
Indometacin
27%
Hypotension
27%
Malignant Neoplasm
18%
Maximum Tolerated Dose
18%
Hydrocortisone
9%
Infarction
9%
Triacylglycerol
9%
Protein C
9%
Kidney Failure
9%
C Reactive Protein
9%
Headache
9%
Preclinical Study
9%
Abdominal Pain
9%
Hypertensive Factor
9%
Chill
9%
Myalgia
9%
Thyrotropin
9%
Nausea and Vomiting
9%